Middlesex Health MultiSpecialty Group

United Statesmiddlesexhealth.org/multispecialty-group

Middlesex Health MultiSpecialty Group is an integrated medical specialty practice affiliated with Middlesex Health, based in Middletown, Connecticut. It delivers specialized outpatient care through providers in fields such as endocrinology, neurology, pulmonology, rheumatology, infectious disease, and sleep medicine.

The group operates as part of the broader Middlesex Health system, which serves Middlesex County and the Connecticut shoreline. It maintains multiple locations and participates in the Mayo Clinic Care Network.

Also known as Middlesex Hospital MultiSpecialty Group.

Latest news on Middlesex Health MultiSpecialty Group

29 September 2026
Novo Nordisk: semaglutide 2 mg linked to lower MACE vs tirzepatide in COMPETE SWITCH CV analysis

Real-world claims analysis found escalating from semaglutide 1 mg to 2 mg tied to a 6% lower risk of major adverse cardiovascular events than switching to tirzepatide.

6 June 2026
Novo Nordisk: semaglutide 2 mg escalation matches tirzepatide for HbA1c <7% and yields greater ≥5% weight loss

Real‑world claims analysis found semaglutide 2 mg escalation gave similar HbA1c <7% rates and higher ≥5% weight‑loss rates than switching to titratable tirzepatide.